Skip to Content

Entacapone

In the US, Entacapone (entacapone systemic) is a member of the drug class dopaminergic antiparkinsonism agents and is used to treat Parkinson's Disease.

US matches:

UK matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N04BX02

CAS registry number (Chemical Abstracts Service)

0130929-57-6

Chemical Formula

C14-H15-N3-O5

Molecular Weight

305

Therapeutic Categories

Treatment of Parkinson's disease

Catechol-O-methyltransferase (COMT) inhibitor

Chemical Name

(E)-2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-dietyl-2-propenamide

Foreign Names

  • Entacaponum (Latin)
  • Entacapon (German)
  • Entacapone (French)
  • Entacapona (Spanish)

Generic Names

  • Entacapone (OS: BAN, USAN, DCF, JAN)
  • OR 611 (Orion) (IS)
  • Entacapon (PH: Ph. Eur. 9, USP 41)
  • Entacapone (PH: BP 2018, Ph. Eur. 9)
  • Entacaponum (PH: Ph. Eur. 9)

Brand Names

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide